{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:43:34Z","timestamp":1773243814951,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH\/NIAID","award":["K23AI114363"],"award-info":[{"award-number":["K23AI114363"]}]},{"name":"NIH\/NIAID","award":["K23AI114363"],"award-info":[{"award-number":["K23AI114363"]}]},{"name":"NIH\/NHLBI","award":["R61\/R33HL146365"],"award-info":[{"award-number":["R61\/R33HL146365"]}]},{"name":"NIH","award":["P30AI027763"],"award-info":[{"award-number":["P30AI027763"]}]},{"name":"UCSF Nina Ireland Program for Lung Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Systematic tuberculosis (TB) screening is recommended for all people with HIV (PWH) because of its potential to improve TB outcomes through earlier diagnosis and treatment initiation. As such, systematic screening may be particularly important for men, who experience excess TB prevalence and mortality compared to women. We assessed sex differences among PWH undergoing systematic TB screening, including TB prevalence and severity, diagnostic accuracy of screening tools, and TB outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We enrolled and followed adults with HIV (CD4\u2009\u2264\u2009350 cells\/\u00b5L) initiating antiretroviral therapy (ART) at two HIV\/AIDS clinics in Uganda from July 2013 to December 2016. All participants underwent TB screening and sputum collection for TB testing (Xpert MTB\/RIF [Xpert], culture). We evaluated diagnostic accuracy of four WHO-recommended TB screening strategies (symptom screen; C-reactive protiein [CRP]; symptom screen followed by CRP, if symptomatic [symptoms\u2009+\u2009CRP]; Xpert) for culture-positive TB and compared TB prevalence, days-to-treatment initiation, and 3-month mortality by sex.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 1,549 participants, 727 (46.9%) were male and 236 (15.2%) had culture-positive TB. Compared to females, males had lower pre-ART CD4 counts (median 139 vs. 183 cells\/\u00b5L, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), higher TB prevalence (20.5% vs. 10.6%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and higher mycobacterial load as measured by Xpert semi-quantitative grade (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). Sensitivity was high (\u2265\u200989.8%) for all screening strategies except Xpert (Xpert sensitivity 57.2%) and did not differ by sex. Specificity varied widely from 13.9% for symptom screen to 99.2% for Xpert, and was 5\u201315% lower for males than females for symptom screen, CRP, and symptoms\u2009+\u2009CRP. Among PWH with culture-positive TB, median days-to-treatment initiation (2 vs. 4, <jats:italic>p<\/jats:italic>\u2009=\u20090.13) and 3-month mortality (9.4% vs. 9.2%, <jats:italic>p<\/jats:italic>\u2009=\u20090.96) were similar for males and females.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Although ART-na\u00efve males undergoing systematic screening had more advanced HIV and TB than females, days-to-TB treatment initiation and early TB mortality were similar, suggesting that systematic TB screening has the potential to reduce sex-based disparities in TB outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-10835-4","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T18:01:14Z","timestamp":1743530474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sex differences in systematic screening for tuberculosis among antiretroviral therapy na\u00efve people with HIV in Kampala, Uganda"],"prefix":"10.1186","volume":"25","author":[{"given":"Lelia H.","family":"Chaisson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred C.","family":"Semitala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Mwebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen P.","family":"Scully","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Katende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Asege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Nakaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred O.","family":"Andama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adithya","family":"Cattamanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"10835_CR1","unstructured":"World Health Organization. Global tuberculosis report 2023. Geneva; 2023."},{"issue":"2","key":"10835_CR2","first-page":"123","volume":"4","author":"MW Borgdorff","year":"2000","unstructured":"Borgdorff MW, Nagelkerke NJ, Dye C, Nunn P. Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection. Int J Tuberc Lung Dis. 2000;4(2):123\u201332.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"10835_CR3","doi-asserted-by":"crossref","first-page":"e1002119","DOI":"10.1371\/journal.pmed.1002119","volume":"13","author":"KC Horton","year":"2016","unstructured":"Horton KC, MacPherson P, Houben RMGJ, White RG, Corbett EL. Sex differences in tuberculosis burden and notifications in Low- and Middle-Income countries: A systematic review and Meta-analysis. PLoS Med. 2016;13(9):e1002119.","journal-title":"PLoS Med"},{"key":"10835_CR4","unstructured":"World Health Organization. National tuberculosis prevalence surveys, 2007\u20132016. Geneva; 2021."},{"issue":"9","key":"10835_CR5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/cid\/ciab527","volume":"73","author":"V Chidambaram","year":"2021","unstructured":"Chidambaram V, Tun NL, Majella MG, Ruelas Castillo J, Ayeh SK, Kumar A, et al. Male sex is associated with worse Microbiological and clinical outcomes following tuberculosis treatment: A retrospective cohort study, a systematic review of the literature, and Meta-analysis. Clin Infect Dis. 2021;73(9):1580\u20138.","journal-title":"Clin Infect Dis"},{"key":"10835_CR6","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis Module 2: Screening\u2013 Systematic screening for tuberculosis disease [Internet]. 2021. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240022676"},{"issue":"11","key":"10835_CR7","first-page":"1183","volume":"9","author":"JE Golub","year":"2005","unstructured":"Golub JE, Mohan CI, Comstock GW, Chaisson RE. Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis. 2005;9(11):1183\u2013203.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9979","key":"10835_CR8","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO\u2019s new end TB strategy. Lancet. 2015;385(9979):1799\u2013801.","journal-title":"Lancet"},{"issue":"2","key":"10835_CR9","first-page":"82","volume":"27","author":"L Lawson","year":"2008","unstructured":"Lawson L, Lawson JO, Olajide I, Emenyonu N, Bello CSS, Olatunji OO, et al. Sex differences in the clinical presentation of urban Nigerian patients with pulmonary tuberculosis. West Afr J Med. 2008;27(2):82\u20136.","journal-title":"West Afr J Med"},{"issue":"12","key":"10835_CR10","first-page":"1621","volume":"14","author":"D Nakanjako","year":"2010","unstructured":"Nakanjako D, Mayanja-Kizza H, Ouma J, Wanyenze R, Mwesigire D, Namale A, et al. Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV\/AIDS clinic in Uganda. Int J Tuberc Lung Dis. 2010;14(12):1621\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10835_CR11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12879-016-2152-4","volume":"17","author":"R Maimaiti","year":"2017","unstructured":"Maimaiti R, Zhang Y, Pan K, Mijiti P, Wubili M, Musa M, et al. High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, China. BMC Infect Dis. 2017;17(1):15.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10835_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12890-017-0430-6","volume":"17","author":"MO Akanbi","year":"2017","unstructured":"Akanbi MO, Achenbach C, Taiwo B, Idoko J, Ani A, Isa Y, et al. Evaluation of gene Xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study. BMC Pulm Med. 2017;17(1):87.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10835_CR13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12879-018-3614-7","volume":"19","author":"KL Bajema","year":"2019","unstructured":"Bajema KL, Bassett IV, Coleman SM, Ross D, Freedberg KA, Wald A, et al. Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort. BMC Infect Dis. 2019;19(1):14.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10835_CR14","doi-asserted-by":"crossref","first-page":"e1004278","DOI":"10.1371\/journal.pmed.1004278","volume":"20","author":"E Klinkenberg","year":"2023","unstructured":"Klinkenberg E, Floyd S, Shanaube K, Mureithi L, Gachie T, de Haas P, et al. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS). PLoS Med. 2023;20(9):e1004278.","journal-title":"PLoS Med"},{"issue":"5","key":"10835_CR15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/QAI.0000000000000085","volume":"65","author":"C Yoon","year":"2014","unstructured":"Yoon C, Davis JL, Huang L, Muzoora C, Byakwaga H, Scibetta C, et al. Point-of-care C-reactive protein testing to facilitate implementation of Isoniazid preventive therapy for people living with HIV. J Acquir Immune Defic Syndr. 2014;65(5):551\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"10835_CR16","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1473-3099(17)30488-7","volume":"17","author":"C Yoon","year":"2017","unstructured":"Yoon C, Semitala FC, Atuhumuza E, Katende J, Mwebe S, Asege L, et al. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study. Lancet Infect Dis. 2017;17(12):1285\u201392.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10835_CR17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1164\/rccm.201803-0490OC","volume":"199","author":"C Yoon","year":"2019","unstructured":"Yoon C, Semitala FC, Asege L, Katende J, Mwebe S, Andama AO, et al. Yield and efficiency of novel intensified tuberculosis Case-Finding algorithms for people living with HIV. Am J Respir Crit Care Med. 2019;199(5):643\u201350.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10835_CR18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/QAD.0000000000002130","volume":"33","author":"LH Chaisson","year":"2019","unstructured":"Chaisson LH, Semitala FC, Asege L, Mwebe S, Katende J, Nakaye M, et al. Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy. AIDS. 2019;33(5):895\u2013902.","journal-title":"AIDS"},{"issue":"4","key":"10835_CR19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/QAI.0000000000002162","volume":"82","author":"FC Semitala","year":"2019","unstructured":"Semitala FC, Cattamanchi A, Andama A, Atuhumuza E, Katende J, Mwebe S, et al. Brief report: yield and efficiency of intensified tuberculosis Case-Finding algorithms in 2 High-Risk HIV subgroups in Uganda. J Acquir Immune Defic Syndr. 2019;82(4):416\u201320.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"10835_CR20","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41591-018-0224-2","volume":"24","author":"MZ Imperial","year":"2018","unstructured":"Imperial MZ, Nahid P, Phillips PPJ, Davies GR, Fielding K, Hanna D, et al. A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. Nat Med. 2018;24(11):1708\u201315.","journal-title":"Nat Med"},{"issue":"1","key":"10835_CR21","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1038\/s41467-024-49317-7","volume":"15","author":"V Riitho","year":"2024","unstructured":"Riitho V, Connon R, Gwela A, Namusanje J, Nhema R, Siika A, et al. Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa. Nat Commun. 2024;15(1):5492.","journal-title":"Nat Commun"},{"issue":"2","key":"10835_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00281-018-0725-6","volume":"41","author":"D Hertz","year":"2019","unstructured":"Hertz D, Schneider B. Sex differences in tuberculosis. Semin Immunopathol. 2019;41(2):225\u201337.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"10835_CR23","doi-asserted-by":"crossref","first-page":"e93831","DOI":"10.1371\/journal.pone.0093831","volume":"9","author":"EI Bini","year":"2014","unstructured":"Bini EI, Mata Espinosa D, Marquina Castillo B, Barrios Pay\u00e1n J, Colucci D, Cruz AF, et al. The influence of sex steroid hormones in the immunopathology of experimental pulmonary tuberculosis. PLoS ONE. 2014;9(4):e93831.","journal-title":"PLoS ONE"},{"issue":"2","key":"10835_CR24","doi-asserted-by":"crossref","first-page":"e00342","DOI":"10.1128\/mBio.00342-16","volume":"7","author":"AM Cadena","year":"2016","unstructured":"Cadena AM, Flynn JL, Fortune SM. The importance of first impressions: early events in Mycobacterium tuberculosis infection influence outcome. mBio. 2016;7(2):e00342\u201300316.","journal-title":"mBio"},{"issue":"1","key":"10835_CR25","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1038\/s41598-017-11438-z","volume":"7","author":"J Dibbern","year":"2017","unstructured":"Dibbern J, Eggers L, Schneider BE. Sex differences in the C57BL\/6 model of Mycobacterium tuberculosis infection. Sci Rep. 2017;7(1):10957.","journal-title":"Sci Rep"},{"issue":"2","key":"10835_CR26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1164\/ajrccm\/142.2.430","volume":"142","author":"Y Yamamoto","year":"1990","unstructured":"Yamamoto Y, Tomioka H, Sato K, Saito H, Yamada Y, Setogawa T. Sex differences in the susceptibility of mice to infection induced by Mycobacterium intracellulare. Am Rev Respir Dis. 1990;142(2):430\u20133.","journal-title":"Am Rev Respir Dis"},{"issue":"11","key":"10835_CR27","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1128\/iai.59.11.4089-4096.1991","volume":"59","author":"Y Yamamoto","year":"1991","unstructured":"Yamamoto Y, Saito H, Setogawa T, Tomioka H. Sex differences in host resistance to Mycobacterium marinum infection in mice. Infect Immun. 1991;59(11):4089\u201396.","journal-title":"Infect Immun"},{"issue":"4","key":"10835_CR28","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.167.4.2060","volume":"167","author":"SM Liva","year":"2001","unstructured":"Liva SM, Voskuhl RR. Testosterone acts directly on CD4\u2009+\u2009T lymphocytes to increase IL-10 production. J Immunol. 2001;167(4):2060\u20137.","journal-title":"J Immunol"},{"issue":"3","key":"10835_CR29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1615\/CritRevEukarGeneExpr.v22.i3.60","volume":"22","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Ying H, Demei J, Xie J. Tuberculosis and sexual inequality: the role of sex hormones in immunity. Crit Rev Eukaryot Gene Expr. 2012;22(3):233\u201341.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"10","key":"10835_CR30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"key":"10835_CR31","unstructured":"Reeve BW, Ndlangalavu G, Mishra H, Palmer Z, Tshivhula H, Rockman L et al. Point-of-care C-reactive protein and Xpert MTB\/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study. medRxiv: the preprint server for health sciences. United States; 2023. p. 2023.05.30.23290716."},{"issue":"6","key":"10835_CR32","doi-asserted-by":"crossref","first-page":"e903","DOI":"10.1016\/S2214-109X(23)00135-3","volume":"11","author":"T Broger","year":"2023","unstructured":"Broger T, Koeppel L, Huerga H, Miller P, Gupta-Wright A, Blanc FX, et al. Diagnostic yield of urine Lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data. Lancet Glob Health. 2023;11(6):e903\u201316.","journal-title":"Lancet Glob Health"},{"issue":"7","key":"10835_CR33","first-page":"604","volume":"5","author":"V Begum","year":"2001","unstructured":"Begum V, de Colombani P, Das Gupta S, Salim AH, Hussain H, Pietroni M, et al. Tuberculosis and patient gender in Bangladesh: sex differences in diagnosis and treatment outcome. Int J Tuberc Lung Dis. 2001;5(7):604\u201310.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10835_CR34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2753.2007.00871.x","volume":"14","author":"W Thongraung","year":"2008","unstructured":"Thongraung W, Chongsuvivatwong V, Pungrassamee P. Multilevel factors affecting tuberculosis diagnosis and initial treatment. J Eval Clin Pract. 2008;14(3):378\u201384.","journal-title":"J Eval Clin Pract"},{"issue":"4","key":"10835_CR35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5588\/ijtld.12.0263","volume":"17","author":"CR Miller","year":"2013","unstructured":"Miller CR, Davis JL, Katamba A, Sserwanga A, Kakeeto S, Kizito F, et al. Sex disparities in tuberculosis suspect evaluation: a cross-sectional analysis in rural Uganda. Int J Tuberc Lung Dis. 2013;17(4):480\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"key":"10835_CR36","volume-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva, Switzerland: World Health Organization; 2018."},{"issue":"5","key":"10835_CR37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/aid.2010.0154","volume":"27","author":"CM Shikuma","year":"2011","unstructured":"Shikuma CM, Ribaudo HJ, Zheng Y, Gulick RM, Meyer WA, Tashima KT, et al. Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals. AIDS Res Hum Retroviruses. 2011;27(5):461\u20138.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"10835_CR38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAI.0000000000001095","volume":"73","author":"JS Mathad","year":"2016","unstructured":"Mathad JS, Gupte N, Balagopal A, Asmuth D, Hakim J, Santos B, et al. Sex-Related differences in inflammatory and immune activation markers before and after combined antiretroviral therapy initiation. J Acquir Immune Defic Syndr. 2016;73(2):123\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10835_CR39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s13063-022-06371-0","volume":"23","author":"FC Semitala","year":"2022","unstructured":"Semitala FC, Chaisson LH, Dowdy DW, Armstrong DT, Opira B, Aman K, et al. Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial. Trials. 2022;23(1):399.","journal-title":"Trials"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10835-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10835-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10835-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T18:02:04Z","timestamp":1743530524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10835-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10835"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10835-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Boards of the University of California San Francisco, Makerere University School of Medicine Research Ethics Committee, and the Uganda National Council for Science and Technology. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}